First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28
首次在健康受试者中开展 FR104（一种 CD28 聚乙二醇化单克隆抗体片段拮抗剂）人体试验
期刊:Journal of Immunology
影响因子:3.6
doi:10.4049/jimmunol.1601538
Nicolas Poirier, Gilles Blancho, Maryvonne Hiance, Caroline Mary, Tim Van Assche, Jos Lempoels, Steven Ramael, Weirong Wang, Virginie Thepenier, Cecile Braudeau, Nina Salabert, Regis Josien, Ian Anderson, Ian Gourley, Jean-Paul Soulillou, Didier Coquoz, Bernard Vanhove
